Yanyang Liu Lang Long Jiewei Liu Lingling Zhu Feng Luo
10.3389/fonc.2021.749682
Front Oncol
2021 Oct 8;11:749682.
fgfr3 anlotinib anti-pd-1 resistance nivolumab pulmonary lymphoepithelioma-like carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/34692530/
Case Reports
PMC8531585
34692530
Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification
2021